Ameritas Investment Partners, Inc. Kezar Life Sciences, Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $9,508 - $12,792	1,190 Added 40.52%	4,127 $35,000
Q1 2022 May 13, 2022	BUY	$12.3 - $18.33 $8,585 - $12,794	698 Added 31.17%	2,937 $49,000
Q1 2020 May 13, 2020	BUY	$2.77 - $5.75 $3,326 - $6,905	1,201 Added 115.7%	2,239 $10,000
Q1 2019 May 15, 2019	BUY	$16.83 - $23.75 $10,569 - $14,915	628 Added 153.17%	1,038 $18,000
Q3 2018 Nov 13, 2018	BUY	$15.5 - $21.41 $6,355 - $8,778	410 New	410 $9,000

1.54M

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $414M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.